Adapted from the author’s contributed chapter in Defining the Value of Spine Care (Rihn, Vaccaro, Albert, and Nash, eds., 2012), NAI President Rita E. Numerof, Ph.D. discusses the progress of comparative effectiveness research (CER) with regard to spine care, what manufacturers can expect and what they should do now to mitigate market access threats inherent in CER.

See the adapted article, The Impact of Comparative Effectiveness Research on Spine Care Device Companies, published in MD&DI, December 4, 2012.